Top companies on the NasdaqGM by Price to Sales Ratio (P/S)

This ranking features the top 297 companies on the NasdaqGM ranked by Price to Sales Ratio (P/S), averaging a Price to Sales Ratio (P/S) of 100.85, for January 15, 2025.

NasdaqGM

All sectors

#	Name	Price to Sales Ratio (P/S)	Reported Date	Stock Price	Change	Country
1	Altimmune, Inc. 1 ALT	8,521.27	Jan. 14, 2025	USD 6.23	-8.11%	United States
2	89bio, Inc. 2 ETNB	3,155.62	Jan. 14, 2025	USD 6.28	-0.47%	United States
3	Trump Media & Technology Group Corp. 3 DJT	2,533.08	Jan. 14, 2025	USD 39.35	-8.30%	United States
4	Sera Prognostics, Inc. 4 SERA	2,288.63	Jan. 14, 2025	USD 6.37	0.63%	United States
5	Trevi Therapeutics, Inc. 5 TRVI	1,995.50	Jan. 14, 2025	USD 3.93	-1.50%	United States
6	Chimerix, Inc. 6 CMRX	1,906.98	Jan. 14, 2025	USD 3.37	1.81%	United States
7	Corvus Pharmaceuticals, Inc. 7 CRVS	1,332.16	Jan. 14, 2025	USD 5.10	-1.92%	United States
8	Structure Therapeutics Inc. 8 GPCR	1,092.72	Jan. 14, 2025	USD 25.38	0.87%	United States
9	Gain Therapeutics, Inc. 9 GANX	851.42	Jan. 14, 2025	USD 2.08	-5.02%	United States
10	Keros Therapeutics, Inc. 10 KROS	776.55	Jan. 14, 2025	USD 12.48	-2.65%	United States
11	Abpro Corporation 11 ABP	543.64	Jan. 14, 2025	USD 1.28	-1.54%	United States
12	Aerovate Therapeutics, Inc. 12 AVTE	524.00	Jan. 14, 2025	USD 2.47	-1.20%	United States
13	Omeros Corporation 13 OMER	364.41	Jan. 14, 2025	USD 8.59	-2.27%	United States
14	Third Harmonic Bio, Inc. 14 THRD	322.85	Jan. 14, 2025	USD 5.99	-8.13%	United States
15	Avidity Biosciences, Inc. 15 RNA	319.00	Jan. 14, 2025	USD 27.05	-4.79%	United States
16	KalVista Pharmaceuticals, Inc. 16 KALV	303.23	Jan. 14, 2025	USD 7.40	-1.60%	United States
17	Neurogene Inc. 17 NGNE	287.30	Jan. 14, 2025	USD 17.89	-4.89%	United States
18	180 Degree Capital Corp. 18 TURN	283.84	Jan. 14, 2025	USD 3.67	0.27%	United States
19	Janux Therapeutics, Inc. 19 JANX	203.77	Jan. 14, 2025	USD 45.35	0.64%	United States
20	Candel Therapeutics, Inc. 20 CADL	196.33	Jan. 14, 2025	USD 7.84	0.90%	United States
21	Aura Biosciences, Inc. 21 AURA	183.67	Jan. 14, 2025	USD 7.56	0.80%	United States
22	Protara Therapeutics, Inc. 22 TARA	142.90	Jan. 14, 2025	USD 5.03	-5.27%	United States
23	Quantum-Si incorporated 23 QSI	141.85	Jan. 14, 2025	USD 2.03	5.18%	United States
24	Ikena Oncology, Inc. 24 IKNA	110.58	Jan. 14, 2025	USD 1.51	-1.95%	United States
25	Rocket Pharmaceuticals, Inc. 25 RCKT	107.55	Jan. 14, 2025	USD 10.43	-2.80%	United States
26	Acrivon Therapeutics, Inc. Common Stock 26 ACRV	91.89	Jan. 14, 2025	USD 5.56	0.91%	United States
27	Orchestra BioMed Holdings, Inc. 27 OBIO	75.68	Jan. 14, 2025	USD 5.27	2.73%	United States
28	SoundHound AI, Inc. 28 SOUN	70.27	Jan. 14, 2025	USD 12.79	-0.23%	United States
29	Cadiz Inc. 29 CDZI	67.29	Jan. 14, 2025	USD 4.96	-5.16%	United States
30	CorMedix Inc. 30 CRMD	54.18	Jan. 14, 2025	USD 11.22	0.90%	United States
31	Rumble Inc. 31 RUM	33.85	Jan. 14, 2025	USD 10.21	-6.50%	United States
32	MicroVision, Inc. 32 MVIS	32.80	Jan. 14, 2025	USD 1.22	2.52%	United States
33	SiTime Corporation 33 SITM	30.75	Jan. 14, 2025	USD 232.96	2.59%	United States
34	Kymera Therapeutics, Inc. 34 KYMR	29.67	Jan. 14, 2025	USD 40.12	7.79%	United States
35	Rhythm Pharmaceuticals, Inc. 35 RYTM	29.46	Jan. 14, 2025	USD 53.94	-1.73%	United States
36	Rani Therapeutics Holdings, Inc. 36 RANI	27.25	Jan. 14, 2025	USD 1.28	-1.54%	United States
37	The Trade Desk, Inc. 37 TTD	24.95	Jan. 14, 2025	USD 116.76	-0.96%	United States
38	Nurix Therapeutics, Inc. 38 NRIX	23.35	Jan. 14, 2025	USD 18.60	-2.16%	United States
39	PROCEPT BioRobotics Corporation 39 PRCT	22.20	Jan. 14, 2025	USD 82.00	-1.10%	United States
40	Ocular Therapeutix, Inc. 40 OCUL	20.13	Jan. 14, 2025	USD 7.86	-3.20%	United States
41	Iovance Biotherapeutics, Inc. 41 IOVA	19.76	Jan. 14, 2025	USD 5.89	1.90%	United States
42	OmniAb, Inc. 42 OABI	18.91	Jan. 14, 2025	USD 3.19	-4.49%	United States
43	Nukkleus Inc. 43 NUKK	18.37	Jan. 14, 2025	USD 16.75	6.48%	United States
44	Winmark Corporation 44 WINA	16.58	Jan. 14, 2025	USD 385.20	0.67%	United States
45	TScan Therapeutics, Inc. 45 TCRX	15.87	Jan. 14, 2025	USD 2.63	-3.31%	United States
46	Xencor, Inc. 46 XNCR	15.70	Jan. 14, 2025	USD 19.11	-5.68%	United States
47	XOMA Corporation 47 XOMA	14.57	Jan. 14, 2025	USD 26.71	5.16%	United States
48	Ligand Pharmaceuticals Incorporated 48 LGND	13.46	Jan. 14, 2025	USD 108.55	2.54%	United States
49	Vertex, Inc. 49 VERX	12.83	Jan. 14, 2025	USD 52.91	0.92%	United States
50	Vericel Corporation 50 VCEL	12.77	Jan. 14, 2025	USD 58.67	-1.59%	United States

1 2 3 4 5 6

Frequently Asked Questions

Which company on the NasdaqGM has the highest Price to Sales Ratio (P/S) ?

The company on the NasdaqGM with the highest Price to Sales Ratio (P/S) is Altimmune, Inc. (NasdaqGM: ALT) at 8,521.27.
Which company on the NasdaqGM has the lowest Price to Sales Ratio (P/S) ?

The company on the NasdaqGM with the lowest Price to Sales Ratio (P/S) is TPI Composites, Inc. (NasdaqGM: TPIC) at 0.05.

What are the top 10 companies on the NasdaqGM by Price to Sales Ratio (P/S) ?

The top 10 companies on the NasdaqGM by Price to Sales Ratio (P/S) are Altimmune, Inc., 89bio, Inc., Trump Media & Technology Group Corp., Sera Prognostics, Inc., Trevi Therapeutics, Inc., Chimerix, Inc., Corvus Pharmaceuticals, Inc., Structure Therapeutics Inc., Gain Therapeutics, Inc. and Keros Therapeutics, Inc..
What are the bottom 10 companies on the NasdaqGM by Price to Sales Ratio (P/S) ?

The bottom 10 companies on the NasdaqGM by Price to Sales Ratio (P/S) are TPI Composites, Inc., Key Tronic Corporation, B. Riley Financial, Inc., Rent the Runway, Inc., Katapult Holdings, Inc., Lulu's Fashion Lounge Holdings, Inc., Star Equity Holdings, Inc., OneWater Marine Inc., Binah Capital Group, Inc. and Patriot National Bancorp, Inc..